И. А. Королева

1.7k total citations
44 papers, 584 citations indexed

About

И. А. Королева is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, И. А. Королева has authored 44 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in И. А. Королева's work include Psoriasis: Treatment and Pathogenesis (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Dermatology and Skin Diseases (3 papers). И. А. Королева is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Dermatology and Skin Diseases (3 papers). И. А. Королева collaborates with scholars based in Russia, United States and Switzerland. И. А. Королева's co-authors include Todd E. Scheetz, Marcelo B. Soares, Maria de Fátima Bonaldo, Thomas L. Casavant, Hakeem Almabrazi, Margaret McFall‐Ngai, Edward G. Ruby, Bartley Brown, Wolfgang Hueber and Vladimir A. Kalsin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

И. А. Королева

33 papers receiving 570 citations

Peers

Countries citing papers authored by И. А. Королева

Since Specialization

Citations

This map shows the geographic impact of И. А. Королева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. А. Королева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. А. Королева more than expected).

Fields of papers citing papers by И. А. Королева

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by И. А. Королева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. А. Королева. The network helps show where И. А. Королева may publish in the future.

Co-authorship network of co-authors of И. А. Королева

This figure shows the co-authorship network connecting the top 25 collaborators of И. А. Королева. A scholar is included among the top collaborators of И. А. Королева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. А. Королева. И. А. Королева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Рак молочной железы 2024 ·Malignant tumours ·(unknown), (unknown), (unknown), (unknown), И. А. Королева, (unknown), Т. Yu. Semiglazova, (unknown), (unknown)	0
2	Anemia and thrombocytopenia induced by antitumor therapy 2023 ·И. А. Королева	1
3	Тошнота и рвота 2023 ·Malignant tumours ·(unknown), (unknown), И. А. Королева, (unknown), Т. Yu. Semiglazova, (unknown), (unknown), Е. Г. Овчинникова, (unknown), (unknown)	1
4	Рак молочной железы 2023 ·Malignant tumours ·(unknown), (unknown), (unknown), И. А. Королева, (unknown), Т. Yu. Semiglazova, (unknown), (unknown)	0
5	Практические рекомендации по лекарственному лечению рака молочной железы 2022 ·Malignant tumours ·(unknown), (unknown), (unknown), (unknown), И. А. Королева, (unknown), Т. Yu. Semiglazova, (unknown), (unknown)	6
6	Практические рекомендации по профилактике и лечению тошноты и рвоты у онкологических больных 2022 ·Malignant tumours ·(unknown), (unknown), И. А. Королева, (unknown), Т. Yu. Semiglazova, (unknown), (unknown), Е. Г. Овчинникова, (unknown), (unknown)	0
7	Практические рекомендации по лекарственному лечению дерматологических реакций у пациентов, получающих противоопухолевую лекарственную терапию 2021 ·Malignant tumours ·И. А. Королева, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
8	IOP-lowering effect of glaucoma surgery: retrospective analysis 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), И. А. Королева, (unknown)	2
9	Pharmacotherapy for AMD: state-of-the-art 2019 ·SHILAP Revista de lepidopterología ·И. А. Королева, (unknown), (unknown)	0
10	Preservative-free IOP-lowering medications: potential advantages 2019 ·Russian Journal of Clinical Ophthalmology ·(unknown), И. А. Королева	1
11	Age-related cataract: prevention and treatment 2018 ·Russian Journal of Clinical Ophthalmology ·И. А. Королева, (unknown)	1
12	Optimization of tear substitute drugs choice in dry eye syndrome therapy 2016 ·Russian Journal of Clinical Ophthalmology ·И. А. Королева, (unknown), (unknown)	1
13	Adjuvant and neoadjuvant therapy of tumors of the gastrointestinal tract. 2015 ·Malignant tumours ·(unknown), И. А. Королева	1
14	Efficiency of accompanying medication with ademetionine (HEPTRAL) during anticancer therapy in patients with cancer of various localization 2015 ·Malignant tumours ·(unknown), (unknown), Mikhail Byakhov, И. А. Королева	2
15	Association ofHLA-DRB1alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis 2015 ·Lara D. Veeken ·Gerd R Burmester, Patrick Durez, (unknown), Mark C. Genovese, Hendrik Schulze‐Koops, (unknown), Ying A. Wang, Steve Lewitzky, И. А. Королева, (unknown), David M. Lee, Wolfgang Hueber	37
16	Multidisciplinary approach in diagnosis and treatment of gastrointestinal stromal tumors. 2015 ·Malignant tumours ·(unknown), И. А. Королева	2
17	Prospective cohort study of clinical characteristics and management patterns for patients with non-small-cell lung cancer in the Russian Federation: EPICLIN-Lung 2015 ·Current Medical Research and Opinion ·Sergei Tjulandin, Evgeny N. Imyanitov, Vladimir Moiseyenko, (unknown), (unknown), И. А. Королева, (unknown)	6
18	Klinicheskie rekomendatsii po profilaktikei lecheniyu toshnoty i rvoty u bol'nykh,poluchayushchikh khimio- i luchevuyuprotivoopukholevuyu terapiyu 2011 ·SHILAP Revista de lepidopterología ·I V Poddubnaya, Mikhail Lichinitser, (unknown), (unknown), (unknown), (unknown), (unknown), Л. В. Болотина, (unknown), Oleg Gladkov, Ірина Давиденко, Lyudmila Zhukova, И. А. Королева, (unknown), George Manikhas, (unknown), (unknown), Р. Ш. Хасанов, (unknown)	1
19	Transcriptional patterns in both host and bacterium underlie a daily rhythm of anatomical and metabolic change in a beneficial symbiosis 2010 ·Proceedings of the National Academy of Sciences ·Andrew M. Wier, Spencer V. Nyholm, Mark J. Mandel, (unknown), Amy L. Schaefer, И. А. Королева, (unknown), Bartley Brown, (unknown), (unknown), Hakeem Almabrazi, Todd E. Scheetz, Maria de Fátima Bonaldo, Thomas L. Casavant, Marcelo B. Soares, John E. Cronan, Jennifer L. Reed, Edward G. Ruby, Margaret McFall‐Ngai	134
20	Effects of colonization, luminescence, and autoinducer on host transcription during development of the squid-vibrio association 2008 ·Proceedings of the National Academy of Sciences ·(unknown), Joshua V. Troll, И. А. Королева, Bartley Brown, (unknown), (unknown), Hakeem Almabrazi, Todd E. Scheetz, Maria de Fátima Bonaldo, Thomas L. Casavant, Marcelo B. Soares, Edward G. Ruby, Margaret McFall‐Ngai	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact